S&P/TSX composite edges up, U.S. markets mixed as Aug. 1 tariff deadline looms
The S&P/TSX composite index was up 47.43 points at 27,364.43.
In New York, the Dow Jones industrial average was up 179.37 points at 44,502.44. The S&P 500 index rose 4.02 points at 6,309.62, while the Nasdaq composite was down 81.49 points at 20,892.69.
The Canadian dollar traded at 73.34 cents US compared with 73.03 cents US on Monday.
The September crude oil contract was down 64 cents US at US$65.31 per barrel.
The August gold contract was up US$37.30 at US$3,443.70 an ounce.
This report by The Canadian Press was first published July 22, 2025.
Companies in this story: (TSX: GSPTSE, TSX: CADUSD)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
23 minutes ago
- Globe and Mail
Enthusiast Gaming Announces Closing of Debt Financing
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (' Enthusiast Gaming ' or the ' Company ') (TSX: EGLX) is pleased to announce the closing of the previously announced debt financing transaction (the ' Transaction '), pursuant to which the Company received a non-revolving term loan in the principal amount of $2,000,000. The Transaction was arranged pursuant to the terms of a forbearance and first supplemental credit agreement among the Company, as borrower, certain subsidiaries of the Company, as guarantors, Beedie Investments Ltd. (' Beedie Capital '), as administrative and collateral agent, and lenders led by Beedie Capital entered into on July 10, 2025. For additional information regarding the Transaction, please refer to the Company's press release dated July 10, 2025. About Enthusiast Gaming Enthusiast Gaming builds tools, platforms, and experiences that gamers use every day. Its portfolio of owned and operated digital properties includes some of the most recognizable names in gaming, such as Icy-Veins, TheSimsResource, PocketGamer, Addicting Games, and Fantasy Football Scout, as well as the global B2B event series PocketGamer Connects. Through these assets, Enthusiast Gaming generates revenue from programmatic advertising, subscriptions, and events, and is focused on expanding its owned IP and deepening direct engagement with its audience. Contacts
CTV News
23 minutes ago
- CTV News
Trump says U.S. will sell ‘so much' beef to Australia
Steaks and other beef products are displayed for sale at a grocery store in McLean, Va. (J. Scott Applewhite/AP Photo) WASHINGTON/CANBERRA — The United States will sell 'so much' beef to Australia, U.S. President Donald Trump said on Thursday after Canberra relaxed import restrictions, adding that other countries that refused U.S. beef products were on notice. Australia on Thursday said it would loosen biosecurity rules for U.S. beef, something analysts predicted would not significantly increase U.S. shipments because Australia is a major beef producer and exporter whose prices are much lower. 'We are going to sell so much to Australia because this is undeniable and irrefutable Proof that U.S. Beef is the Safest and Best in the entire World,' Trump said in a post on Truth Social. 'The other Countries that refuse our magnificent Beef are ON NOTICE,' the post continued. Trump has attempted to renegotiate trade deals with numerous countries he says have taken advantage of the United States – a characterization many economists dispute. 'For decades, Australia imposed unjustified barriers on U.S. beef,' U.S. Trade Representative Jamieson Greer said in a statement, calling Australia's decision a 'major milestone in lowering trade barriers and securing market access for U.S. farmers and ranchers.' Australia is not a significant importer of beef but the United States is and a production slump is forcing it to step up purchases. Last year, Australia shipped almost 400,000 metric tons of beef worth US$2.9 billion to the United States, with just 269 tons of U.S. product moving the other way. Australian officials say the relaxation of restrictions was not part of any trade negotiations but the result of a years-long assessment of U.S. biosecurity practices. Canberra has restricted U.S. beef imports since 2003 due to concerns about bovine spongiform encephalopathy (BSE), or mad cow disease. Since 2019, it has allowed in meat from animals born, raised and slaughtered in the U.S. but few suppliers were able to prove that their cattle had not been in Canada and Mexico. On Wednesday, Australia's agriculture ministry said U.S. cattle traceability and control systems had improved enough that Australia could accept beef from cattle born in Canada or Mexico and slaughtered in the United States. The decision has caused some concern in Australia, where biosecurity is seen as essential to prevent diseases and pests from ravaging the farm sector. 'We need to know if (the government) is sacrificing our high biosecurity standards just so Prime Minister Anthony Albanese can obtain a meeting with U.S. President Donald Trump,' shadow agriculture minister David Littleproud said in a statement. Australia, which imports more from the U.S. than it exports, faces a 10 per cent across-the-board U.S. tariff, as well 50 per cent tariffs on steel and aluminum. Trump has also threatened to impose a 200 per cent tariff on pharmaceuticals. Asked whether the change would help achieve a trade deal, Australian Trade Minister Don Farrell said: 'I'm not too sure.' 'We haven't done this in order to entice the Americans into a trade agreement,' he said. 'We think that they should do that anyway.' (Reporting by Kanishka Singh, Ismail Shakil and Peter Hobson; Editing by Ross Colvin, Christian Schmollinger, Jamie Freed and Lincoln Feast.)
Globe and Mail
23 minutes ago
- Globe and Mail
Castle Biosciences' Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal
FRIENDSWOOD, Texas, July 25, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its founder, president and chief executive officer Derek Maetzold has been named a 2025 Most Admired CEO by the Houston Business Journal. This prestigious honor celebrates leaders who have demonstrated outstanding financial stewardship, fostered inclusive and thriving workplace cultures, and made meaningful contributions to the greater Houston community. 'Derek's visionary leadership and unwavering values have shaped Castle Biosciences into what it is today: a company focused on improving patient outcomes through innovative diagnostic tests for skin cancers, Barrett's esophagus and uveal melanoma,' said Frank Stokes, chief financial officer of Castle Biosciences. 'Over nearly two decades, his leadership approach has exemplified how great vision and values can drive meaningful progress – building a company culture where patient needs remain at the center of strategic decisions and where personalized disease insights can translate into better care for those who need it most.' 'I am truly honored to receive this recognition from the Houston Business Journal,' said Maetzold. "This award validates our core belief that lasting impact comes from doing right by our team and never losing sight of the patients who depend on our work.' The award recipients will be honored at a special event held by the Houston Business Journal in August. About Castle Biosciences Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors. Castle's current portfolio consists of tests for skin cancers, Barrett's esophagus and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit and connect with us on LinkedIn, Facebook, X and Instagram. DecisionDx-Melanoma, DecisionDx-CM Seq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UM Seq are trademarks of Castle Biosciences, Inc. Investor Contact: Camilla Zuckero czuckero@ Media Contact: Allison Marshall amarshall@ Source: Castle Biosciences Inc. Photos accompanying this announcement are available at:
